Assessment of Metabolic Syndrome in Patients with Chronic Obstructive Pulmonary Disease: A 6-Month Follow-Up Study
Beurteilung des metabolischen Syndroms bei Patient:innen mit chronisch obstruktiver Lungenerkrankung: 6-Monats-Follow-up-Studie
Diagnostics · 31.10.2024 · 14 (21) · 2437
DOI: 10.3390/diagnostics14212437 ↗Auf einen Blick
Bei 100 Patient:innen mit COPD war das metabolische Syndrom mit höheren Nüchternglukose- und Triglyzeridwerten verbunden. Nach 6 Monaten verbesserten sich mehrere Parameter unter multidisziplinärer Rehabilitation.
Fragestellung
Welchen Einfluss hat das metabolische Syndrom auf die Lungenfunktion bei COPD, und welche Rolle spielt Selbstmanagement im 6-Monats-Verlauf?
Methode
Prospektive Kohortenstudie mit 100 Patient:innen in einem Rehabilitationskrankenhaus; Vergleich mit und ohne MetS; Baseline und 6 Monate.
Ergebnisse
MetS war mit höherer Nüchternglukose (p = 0,004) und Triglyzeriden (p = 0,003) assoziiert, nicht mit Interleukinen oder TNF-alpha. BMI korrelierte mit FEV1 (r = 0,389; p = 0,001) und FEV1/FVC (r = 0,508; p < 0,001).
Schlussfolgerung der Autor:innen
MetS ist bei COPD eine häufige Komorbidität und mit höherem BMI, Nüchternglukose- und Triglyzeridwerten verbunden, nicht mit Entzündungsparametern. Die kombinierte pulmonal-kardiovaskuläre Rehabilitation verbessert verschiedene Parameter.
Kernaussagen
- MetS bei COPD mit höherer Nüchternglukose und Triglyzeriden verbunden
- Nach 6 Monaten verbesserten sich mehrere klinische Parameter
- Kein Zusammenhang mit Interleukinen oder TNF-alpha
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 31.10.2024. Verfasst von Elena-Andreea Moaleș und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Specialities I, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No. 16, 700115 Ia…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grigore T. Popa University of Medicine and Pharmacy, ”Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania.
Themen: COPD
Abstract (Originalsprache)
Background/Objectives: The association between chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) is a common one, with long-term therapeutic and prognostic impact. In view of the high pulmonary and cardiovascular morbidity and mortality, self-management contributes to decreasing the risk of an acute cardiac event or pulmonary decompensation.
Methods
We conducted a prospective cohort study on 100 patients admitted to Iasi Clinical Rehabilitation Hospital who were divided into two groups according to the presence (67 patients) or absence (33 patients) of MetS. All patients benefited from multidisciplinary counseling sessions on their active role in improving modifiable cardiovascular risk factors and thus increasing quality of life. The aim of this study was to examine the impact of metabolic syndrome on lung function and the role of self-management in a 6-month follow-up period. The demographic, anthropometric, cardiovascular risk factors, and respiratory function were analyzed at baseline and at 6 months.
Results
The presence of MetS was associated with higher fasting blood glucose (p = 0.004) and triglycerides (p = 0.003) but not with higher levels of interleukins or TNF-alpha. At the 6-month follow-up, abdominal circumference, forced expiratory volume in one second (FEV1), dyspnea severity, and blood pressure values improved in male patients with COPD. Systolic and diastolic blood pressure decreased in the COPD group as a whole, but especially in male patients with and without associated MetS. BMI was positively correlated with FEV1 (r = 0.389, p = 0.001) and the FEV1/forced vital capacity (FVC) ratio (r = 0.508, p < 0.001) in all COPD patients and in the MetS subgroup. In the COPD group as a whole. the six-minute walk test (6MWT) results (m) were positively correlated with FEV1 and FVC. The correlation remained significant for FVC in COPD patients with and without MetS. An increase in BMI by one unit led to an increase in TG values by 3.358 mg/dL, and the presence of metabolic syndrome led to an increase in TG values by 17.433 mg/dL.
Conclusions
In our study, MetS is a common comorbidity in patients with COPD and is associated with higher BMI, fasting glucose, and triglycerides but not with the inflammatory parameters. A mixed pulmonary–cardiovascular rehabilitation intervention leads to improvement in various parameters in both female and male COPD patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Specialities I, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No. 16, 700115 Iași, Romania.
- Clinical Rehabilitation Hospital, Pantelimon Halipa Street No. 14, 700661 Iași, Romania.
- Pharmacology, Clinical Pharmacology and Algeziology, Department of Morpho-Functional Sciences II, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No. 16, 700115 Iași, Romani…
- Saint Mary Emergency Children Hospital, 700887 Iași, Romania.
- Advanced Research and Development Center for Experimental Medicine "Prof. Ostin C. Mungiu"-CEMEX, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
- Department of Preventive Medicine and Interdisciplinarity, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street No. 16, 700115 Iași, Romania.
ORCID-Profile: Elena-Andreea Moaleș, Doina-Clementina Cojocaru, Ioana Mădălina Zota, Cristina Mihaela Ghiciuc, Cristina Andreea Adam, Mitică Ciorpac, Florin Dumitru Petrariu, Romică Sebastian Cozma, Florin Mitu
Förderung
- Grigore T. Popa University of Medicine and Pharmacy
- ”Grigore T. Popa” University of Medicine and Pharmacy Iasi, Romania
Zitieren
APA
Moaleș, E. A., Dima-Cozma, L. C., Cojocaru, D. C., Zota, I. M., Ghiciuc, C. M., Adam, C. A., Ciorpac, M., Tudorancea, I. M., Petrariu, F. D., Leon, M. M., Cozma, R. S., & Mitu, F. (2024). Assessment of Metabolic Syndrome in Patients with Chronic Obstructive Pulmonary Disease: A 6-Month Follow-Up Study. Diagnostics, 14(21), 2437. https://doi.org/10.3390/diagnostics14212437
Vancouver
Moaleș EA, Dima-Cozma LC, Cojocaru DC, Zota IM, Ghiciuc CM, Adam CA, et al. Assessment of Metabolic Syndrome in Patients with Chronic Obstructive Pulmonary Disease: A 6-Month Follow-Up Study. Diagnostics. 2024;14(21):2437. doi:10.3390/diagnostics14212437
BibTeX
@article{Moale2024,
author = {Moaleș, Elena-Andreea and Dima-Cozma, Lucia Corina and Cojocaru, Doina-Clementina and Zota, Ioana Mădălina and Ghiciuc, Cristina Mihaela and Adam, Cristina Andreea and Ciorpac, Mitică and Tudorancea, Ivona Maria and Petrariu, Florin Dumitru and Leon, Maria-Magdalena and Cozma, Romică Sebastian and Mitu, Florin},
title = {Assessment of Metabolic Syndrome in Patients with Chronic Obstructive Pulmonary Disease: A 6-Month Follow-Up Study},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {21},
pages = {2437},
doi = {10.3390/diagnostics14212437}
}
EUVIMED